CiteScore measures average citations received per document published in the serial.
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Indexed in the following public directories
Overview | |
Publisher | BENTHAM SCIENCE PUBL LTD |
Language | English |
Frequency | Bi-monthly |
General Details | |
Language | English |
Frequency | Bi-monthly |
Publication Start Year | 2001 |
Publisher URL | Visit website |
Website URL | Visit website |
Upload your Manuscript to get
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my Paper1.8k articles received 14k citations see all
Endocrine, Metabolic and Immune Disorders - Drug Targets has been in operation since 2001 till date.
Endocrine, Metabolic and Immune Disorders - Drug Targets published with a Bi-monthly frequency.
For Endocrine, Metabolic and Immune Disorders - Drug Targets,eISSN is 2212-3873 and pISSN is1871-5303.
Citescore for Endocrine, Metabolic and Immune Disorders - Drug Targets is 3.8.
SNIP score for Endocrine, Metabolic and Immune Disorders - Drug Targets is 0.7.
BENTHAM SCIENCE PUBL LTD is the publisher of Endocrine, Metabolic and Immune Disorders - Drug Targets.